According to the latest report by IMARC Group “Wearable Injectors Market: Global Industry Trends, Size, Share, Growth, Opportunity and Forecast 2022-2027“, The global wearable injectors market reached a value of US$ 5.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 14.4 Billion by 2027, exhibiting a CAGR of 16.75% during 2022-2027. Wearable injectors, also known as patch pumps, are drug delivery systems comprising a reservoir to store drugs, a cannula for substance delivery to tissues, and a drive system for delivering preset doses to patients automatically. They are comfortable and assist in delivering viscous medications in larger amounts quickly and safely through the subcutaneous tissues in the body. Unlike traditionally used injections, wearable injectors are user-friendly, cause minimal pain and are easy to dispose of. Request for a free sample copy of this report: https://www.imarcgroup.com/wearable-injectors-market/requestsample Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. Market Trends: The growing geriatric population, which is more susceptible to chronic medical ailments, represents one of the key factors positively influencing the market. In line with this, the rising demand for minimally invasive (MI) treatment alternatives and escalating demand for home-based treatment among the patients are other major factors creating a positive outlook for the market. Furthermore, increasing investment in healthcare infrastructure and services and research and development (R&D) activities are anticipated to drive the market. Breakup by Type:
- On-body
- Off-body
- Spring-based
- Motor-driven
- Rotary Pump
- Expanding Battery
- Others
- Oncology
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Others
- Hospitals and Clinics
- Home Care
- Others
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
- Becton Dickinson and Company
- CeQur SA
- Debiotech SA
- Dexcom Inc.
- Enable Injections Inc.
- Gerresheimer AG
- Insulet Corporation
- Tandem Diabetes Care Inc.
- West Pharmaceutical Services Inc.
- Ypsomed AG.